DSIP
Also called Delta sleep-inducing peptide
Intravenous (into a vein)Human study reference
Research reference
Human study
DSIP six-volunteer sleep experiment
Slow morning IV infusion of 25 nmol/kg
Immediate observation over 130 minutes and subsequent night sleep
Schneider-Helmert et al. (1981) ↗When results may show
- When change was measured
- This tiny early study measured sleep behavior, not a repeated nightly under-the-skin insomnia course.
- When to assess
- Immediate observation over 130 minutes and subsequent night sleep
- Conditions and limitations
- Six healthy volunteers in a double-blind crossover experiment. Weight-based IV exposure cannot define fixed-mcg home injections or a durable sleep result; no maintenance protocol is established.
- When to stop
- The measured study window is not a validated personal quit rule. Do not increase or prolong exposure because an expected result is absent; severe or persistent reactions need prompt clinical review.
Sources: Schneider-Helmert et al. (1981)
Research timing is descriptive, not a promise or personal instruction. A severe or persistent reaction needs prompt clinical review. This is not medical advice.
Modelled level — every day
1× is the peak after a single dose.
- Steady-state peak
- 1.00× single dose
- Time to steady state
- 2hours
- Administrations
- 7/ week
Read off the modelled curve, not an even-interval formula
About five half-lives
Where these numbers come from
- Schneider-Helmert et al. (1981)Weight-based IV exposure cannot define fixed-mcg home injections or a durable sleep result; no maintenance protocol is established.